Health Trials

Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Safety and Tolerability Study of Mesenchymal Stem Cells, HeXell-2020, in Elderly Subjects With Mild to Moderate Frailty Syndrome

This is a phase I study to investigate the safety, and Tolerability of HeXell-2020 in Elderly Subjects with Mild to Moderate Frailty Syndrome. HeXell-2020 is an investigational drug product consisting of allogenic umbilical cord mesenchymal stem cells (UCMSCs) as the drug substance. All enrolled and eligible subjects will receive HeXell-2020 treatment.

Participants needed: 12
Trial details
Phase: Phase 1Age: 60-85Biological sex: AllType: InterventionalSponsor: Hexun Biosciences Co., LTD.Updated: Sep 4, 2025
Eligibility criteria

Subjects aged ≥ 60 through ≤ 85 years old. [+4]

Subjects unwilling or unable to perform any of the assessments required by endpo... [+21]

Read more
Status: Not yet recruiting

Safety and Preliminary Effectiveness Study of Mesenchymal Stem Cells, HeXell-2020, in Patients With Stable Coronary Artery Disease

This is a phase I/IIa study to investigate the safety, tolerability, and preliminary effectiveness of HeXell-2020 in patients with stable coronary artery disease (CAD). HeXell-2020 is an investigational drug product consisting of allogenic umbilical cord mesenchymal stem cells (UCMSCs) as the drug substance. All enrolled and eligible subjects will receive HeXell-2020 treatment.

Participants needed: 39
Trial details
Phase: Phase 1, Phase 2Age: 18-75Biological sex: AllType: InterventionalSponsor: Hexun Biosciences Co., LTD.Updated: Aug 22, 2025
Eligibility criteria

Subject who is able to understand the nature of this study and accepts to enter... [+11]

Subject had participated in investigational drug trials and took any investigati... [+24]

Read more